|Dec 2014||Dec 2013||Dec 2012||Dec 2011|
|Cash Flow From Operating Activities|
|Net Income (Loss)||-18.73M||-12.32M||-16.42M||-9.86M|
|Extraordinary Gains / Losses||0.00||0.00||0.00||0.00|
|(Increase) Decrease In Receivables||-483.81K||-569.12K||-866.00K||50.30K|
|(Increase) Decrease in Inventories||0.00||0.00||0.00||0.00|
|(Increase) Decrease In Other Current Assets||0.00||0.00||0.00||0.00|
|(Decrease) Increase In Payables||360.87K||181.82K||20.32K||416.20K|
|(Decrease) Increase In Other Current Liabilities||0.00||0.00||0.00||0.00|
|(Increase) Decrease In Other Working Capital||0.00||0.00||0.00||0.00|
|Other Non-Cash Items||1.80M||3.04M||1.90M||4.77M|
|Net Cash From Continuing Operations||-16.81M||-9.54M||-15.19M||-4.56M|
|Net Cash From Discontinued Operations||0.00||0.00||0.00||0.00|
|Cash Provided By Investing Activities|
|Net Cash From Total Operating Activities||-16.81M||-9.54M||-15.19M||-4.56M|
|Sale of Property, Plant & Equipment||1.75K||0.00||0.00||77.07K|
|Cash Used for Investing Activities|
|Sale of Short-Term Investments||0.00||0.00||0.00||51.83M|
|Purchases of Property, Plant & Equipment||-92.21K||-153.01K||-104.98K||-260.40K|
|Purchases of Short-Term Investments||0.00||0.00||-69.15M||-42.14M|
|Other Cash from Investing Activities||13.88K||13.92K||41.63K||261.09K|
|Cash Provided by Financing Activities|
|Net Cash From Investing Activities||16.27M||-13.62M||-23.00M||9.78M|
|Issuance of Debt||0.00||0.00||30.00M||0.00|
|Cash Used for Financing Activities|
|Issuance of Capital Stock||282.80K||20.26M||5.98M||2.08M|
|Repayment of Long-Term Debt||0.00||0.00||0.00||0.00|
|Repurchase of Capital Stock||0.00||0.00||0.00||0.00|
|Payment of Cash Dividends||0.00||0.00||0.00||0.00|
|Other Financing Charges, Net||-1.59M||-261.48K||-160.24K||0.00|
|Net Cash From Financing Activities||-1.30M||20.00M||35.82M||2.08M|
|Effect of Exchange Rate Changes||0.00||0.00||0.00||0.00|
|Net Change in Cash & Cash Equivalents||-1.84M||-3.16M||-2.37M||7.29M|
|Rating||Current||1-Mo Ago||2-Mo Ago||3-Mo Ago|
|GET CRIS ANALYST REPORT|
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.